The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Naval Daver | EHA 2018 | Immune-based therapy in AML

Jun 19, 2018

23 rdCongress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden

Naval Daver: MD Anderson Cancer Center, Houston, US

Interview topic: Immune-based therapy in AML

Immune-based therapy in AML